Published in Am J Epidemiol on March 26, 2014
Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA (2008) 5.59
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis (2006) 4.26
Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol (2010) 4.06
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol (2002) 3.37
Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet (2010) 2.76
Causation in epidemiology. J Epidemiol Community Health (2001) 2.50
Association between serum uric acid and development of type 2 diabetes. Diabetes Care (2009) 2.49
Fructose-induced hyperuricaemia. Lancet (1970) 1.66
Allopurinol treatment and its effect on renal function in gout: a controlled study. Ann Rheum Dis (1982) 1.65
Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol (2014) 1.50
Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol (2002) 1.39
Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med (2010) 1.39
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients. Iran J Kidney Dis (2010) 1.23
THE RENAL LESION IN GOUT. Ann Intern Med (1965) 1.22
No evidence for a causal link between uric acid and type 2 diabetes: a Mendelian randomisation approach. Diabetologia (2011) 0.99
The interrelationship of glycogen storage disease and gout. Arthritis Rheum (1965) 0.93
Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol (2013) 0.83
Re: "Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population". Am J Epidemiol (2014) 0.78
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med (2007) 6.09
Brief communication: clinical implications of short-term variability in liver function test results. Ann Intern Med (2008) 5.27
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07
Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010. Ann Intern Med (2014) 4.00
Chronic hyperglycemia and subclinical myocardial injury. J Am Coll Cardiol (2012) 3.91
Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2010) 3.37
Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol (2009) 3.05
Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care (2007) 2.92
Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation (2004) 2.83
Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis (2010) 2.83
Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis (2008) 2.64
Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol (2009) 2.43
Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med (2014) 2.20
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose. Clin Chem (2012) 2.00
Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2012) 1.98
The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study. Diabetes (2010) 1.94
Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006. Diabetes Care (2010) 1.92
Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging (2012) 1.85
Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) (2012) 1.83
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2011) 1.78
Metals in urine and peripheral arterial disease. Environ Health Perspect (2005) 1.76
Hemoglobin A1c predicts healing rate in diabetic wounds. J Invest Dermatol (2011) 1.73
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis (2013) 1.54
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J Am Soc Nephrol (2007) 1.53
Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study. Arch Intern Med (2008) 1.52
Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities). JACC Heart Fail (2013) 1.51
Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study). Am J Cardiol (2010) 1.50
Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population. Am J Epidemiol (2014) 1.50
Within-person variability in high-sensitivity C-reactive protein. Arch Intern Med (2012) 1.48
Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control (2009) 1.43
Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Soc Nephrol (2008) 1.40
NH2-terminal pro-brain natriuretic peptide and risk of diabetes. Diabetes (2013) 1.35
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation (2015) 1.33
Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004. Cancer Causes Control (2010) 1.29
Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. Arch Intern Med (2010) 1.24
Does genetic ancestry explain higher values of glycated hemoglobin in African Americans? Diabetes (2011) 1.23
Alternative markers of hyperglycemia and risk of diabetes. Diabetes Care (2012) 1.23
No ethnic differences in the association of glycated hemoglobin with retinopathy: the national health and nutrition examination survey 2005-2008. Diabetes Care (2012) 1.23
Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep (2014) 1.22
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2005) 1.21
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart (2011) 1.16
Calibration of cystatin C in the National Health and Nutrition Examination Surveys (NHANES). Am J Kidney Dis (2012) 1.16
African ancestry and its correlation to type 2 diabetes in African Americans: a genetic admixture analysis in three U.S. population cohorts. PLoS One (2012) 1.12
Perceptions of cancer in an African-American community: a focus group report. Ethn Dis (2002) 1.11
Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol (2013) 1.11
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care (2015) 1.10
Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. J Gen Intern Med (2013) 1.09
Serum fructosamine and glycated albumin and risk of mortality and clinical outcomes in hemodialysis patients. Diabetes Care (2012) 1.07
Blood pressure and the risk of developing diabetes in african americans and whites: ARIC, CARDIA, and the framingham heart study. Diabetes Care (2011) 1.05
Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis (2013) 1.05
Education and cognitive change over 15 years: the atherosclerosis risk in communities study. J Am Geriatr Soc (2012) 1.04
Diabetes and risk of fracture-related hospitalization: the Atherosclerosis Risk in Communities Study. Diabetes Care (2012) 1.01
Transcription factor 7-like 2 (TCF7L2) polymorphism and context-specific risk of type 2 diabetes in African American and Caucasian adults: the Atherosclerosis Risk in Communities study. Diabetes (2008) 1.01
Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III). BMC Nephrol (2012) 0.99
Creation, validation, and quantitative analysis of protein expression in vascular tissue microarrays. Cardiovasc Pathol (2009) 0.99
Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S. Diabetes Care (2013) 0.98
Low hemoglobin A(1c) in nondiabetic adults: an elevated risk state? Diabetes Care (2012) 0.98
Comparison of two assays for serum 1,5-anhydroglucitol. Clin Chim Acta (2011) 0.97
Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006. Int J Cancer (2012) 0.96
Strength of association for incident diabetes risk factors according to diabetes case definitions: the Atherosclerosis Risk in Communities Study. Am J Epidemiol (2012) 0.95
Cognition and incident dementia hospitalization: results from the atherosclerosis risk in communities study. Neuroepidemiology (2012) 0.95
Racial differences in nonalcoholic fatty liver disease in the U.S. population. Obesity (Silver Spring) (2013) 0.93
Use of human vascular tissue microarrays for measurement of advanced glycation endproducts. J Histochem Cytochem (2009) 0.93
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) (2011) 0.93
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 0.92
Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States. Am Heart J (2013) 0.92
Socioeconomic status and the trajectory of self-rated health. Age Ageing (2011) 0.91
Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care (2012) 0.91
Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males. Cancer Causes Control (2013) 0.89
The effects of freeze-thaw on β-trace protein and β2-microglobulin assays after long-term sample storage. Clin Biochem (2012) 0.89
The metabolic syndrome and cognitive decline in the Atherosclerosis Risk in Communities study (ARIC). Dement Geriatr Cogn Disord (2014) 0.88
Hyperglycemia and arterial stiffness: the Atherosclerosis Risk in the Communities study. Atherosclerosis (2012) 0.87
Low glycated hemoglobin and liver disease in the U.S. population. Diabetes Care (2011) 0.87
Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. Am J Prev Med (2012) 0.86
Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: re-visiting glycated haemoglobin targets for cardiovascular disease prevention. Diabetes Obes Metab (2007) 0.85
A conundrum addressed: the prognostic value of HbA1c. Nat Rev Endocrinol (2011) 0.82
Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet (2014) 0.81
Glycemia (hemoglobin A1c) and incident venous thromboembolism in the Atherosclerosis Risk in Communities cohort study. Vasc Med (2013) 0.80
Hemoglobin A1c and arterial and ventricular stiffness in older adults. PLoS One (2012) 0.79
A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations. J Clin Endocrinol Metab (2015) 0.78
The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study. Am J Epidemiol (2016) 0.78
Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. Cancer Causes Control (2010) 0.77
Spousal Influence on Physical Activity in Middle-Aged and Older Adults: The ARIC Study. Am J Epidemiol (2015) 0.77
Glomerular protein levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 are lower in diabetic subjects. J Histochem Cytochem (2009) 0.77
Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study. Ann Epidemiol (2013) 0.77
Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). Nephrol Dial Transplant (2010) 0.76
Serum fibroblast growth factor-23 and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. J Hypertens (2016) 0.75
Response to Letter Regarding Article, “Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk In the Community Study”. Circ Heart Fail (2015) 0.75
Changes in Body Mass Index and Obesity Risk in Married Couples Over 25 Years: The ARIC Cohort Study. Am J Epidemiol (2015) 0.75
Severe Hypoglycemia and Elevated High-Sensitivity Cardiac Troponin T in Older Adults With Diabetes: The ARIC Study. J Am Coll Cardiol (2016) 0.75
Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study. J Hypertens (2016) 0.75
Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease. Am J Epidemiol (2017) 0.75
The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity. Alzheimer Dis Assoc Disord (2017) 0.75
Sex Differences in the Association of Diabetes With Cardiovascular Disease Outcomes Among African Americans and Whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (2017) 0.75
Reply: Diastolic Blood Pressure: Myocardial Damage and Coronary Ischemic Events. J Am Coll Cardiol (2017) 0.75